FLASH SPRING SALE: 50% Off Premium Subscription >> FLASH SPRING SALE: 50% Off Premium >>
NASDAQ:CNAT
Delisted

Conatus Pharmaceuticals Inc. Stock Price (Quote)

NASDAQ Stock Exchange
Open Broker Account
$0.255
+0 (+0%)
At Close: May 27, 2022
Forecast Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $0.255 $0.255 Friday, 27th May 2022 CNAT stock ended at $0.255. During the day the stock fluctuated 0% from a day low at $0.255 to a day high of $0.255.
90 days $0.238 $0.275
52 weeks $0.203 $1.23

Historical Conatus Pharmaceuticals Inc. prices

Date Open High Low Close Volume
May 27, 2022 $0.255 $0.255 $0.255 $0.255 0
May 26, 2022 $0.255 $0.255 $0.255 $0.255 0
May 25, 2022 $0.255 $0.255 $0.255 $0.255 0
May 24, 2022 $0.255 $0.255 $0.255 $0.255 0
May 23, 2022 $0.255 $0.255 $0.255 $0.255 0
May 20, 2022 $0.255 $0.255 $0.255 $0.255 0
May 19, 2022 $0.255 $0.255 $0.255 $0.255 0
May 18, 2022 $0.255 $0.255 $0.255 $0.255 0
May 17, 2022 $0.255 $0.255 $0.255 $0.255 0
May 16, 2022 $0.255 $0.255 $0.255 $0.255 0
May 13, 2022 $0.255 $0.255 $0.255 $0.255 0
May 12, 2022 $0.255 $0.255 $0.255 $0.255 0
May 11, 2022 $0.255 $0.255 $0.255 $0.255 0
May 10, 2022 $0.255 $0.255 $0.255 $0.255 0
May 09, 2022 $0.255 $0.255 $0.255 $0.255 0
May 06, 2022 $0.255 $0.255 $0.255 $0.255 0
May 05, 2022 $0.255 $0.255 $0.255 $0.255 0
May 04, 2022 $0.255 $0.255 $0.255 $0.255 0
May 03, 2022 $0.255 $0.255 $0.255 $0.255 0
May 02, 2022 $0.255 $0.255 $0.255 $0.255 0
Apr 29, 2022 $0.255 $0.255 $0.255 $0.255 0
Apr 28, 2022 $0.255 $0.255 $0.255 $0.255 0
Apr 27, 2022 $0.255 $0.255 $0.255 $0.255 0
Apr 26, 2022 $0.255 $0.255 $0.255 $0.255 0
Apr 25, 2022 $0.255 $0.255 $0.255 $0.255 0
Click to get the best stock tips daily for free!

About Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals. Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. Its product candidates include Emricasan, an orally active pan-caspase protease inhibitor that is in Phase II clinical trials for the treatment of liver cirrhosis, acute-on-chronic liver failure, post-orthotopic liver transplant as a result of hepatitis C virus infection with sust... CNAT Profile

Golden Star

Ticker Date Change Price
ETSY Apr 26 1.84% $67.43
DHT Apr 24 1.24% $11.28
LPLA Apr 19 2.49% $262.59
MLI Apr 19 6.77% $52.28
PFLT Apr 18 1.07% $11.25
DOOR Apr 18 0.88% $131.39
LNG Apr 17 0.644% $156.81
FCN Apr 16 2.99% $207.62
ELV Apr 16 4.26% $506.97
ITCI Apr 05 4.92% $68.44
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT